RecruitingNCT04626440

Research on the Heterogeneity of Taiwanese Breast Cancer Patients by Next Generation Sequencing (NGS) Tools

Comprehensive Precision Medicine Research on the Heterogeneity of Taiwanese Breast Cancer Patients by Next Generation Sequencing (NGS) Tools


Sponsor

vghtpe user

Enrollment

1,875 participants

Start Date

Nov 22, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

The objectives of this study are: 1. To determine the difference in genetic profiling of subjects with breast cancer recurrence 2. To determine the comprehensive genetic profiling of subjects with late stage breast cancer 3. To determine the potential biomarkers for early detection and prognosis for breast cancer 4. To determine the genetic profiling of immune system in different subtypes of breast cancer By integrating and analyzing the data generated using the methods of NGS, these information can be used for: 1. Understanding the genetic profiling of different subtypes of breast cancer in Taiwan 2. Assessing the efficacy of different treatments in breast cancer subjects 3. Defining the molecular risk factors and predicting the potential risk of breast cancer recurrence 4. Assessing the immune repertoire and the potential effects of immunotherapy in breast cancer subjects 5. Developing new strategies in treating patients with triple negative or late stage of breast cancer


Eligibility

Sex: FEMALEMin Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting genetic information from Taiwanese women with breast cancer to understand why the disease looks and behaves so differently between patients. By analyzing tumor tissue using advanced gene sequencing technology, researchers hope to identify patterns that can guide more personalized treatment. **You may be eligible if...** - You are a woman aged 20 or older - You have been diagnosed with invasive breast cancer and are planning treatment - You have had a recurrence: either within 3 years after surgery, or a stage IV diagnosis beyond 3 years after surgery (with original tumor tissue available) - Your general health score (ECOG) is 3 or better - Your life expectancy is at least 3 months **You may NOT be eligible if...** - You have had another primary cancer (other than breast cancer) in the past 5 years Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREDiagnostic stage or the Clinical outcome

After enrollment, individual subject will be assigned into one of the four groups according to the medical management received, the diagnostic stage of breast cancer (BC), or the clinical outcome of BC at enrollment.


Locations(1)

Taipei Veterans General Hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04626440


Related Trials